Clinical Trials Browser

INDUSTRY × tesetaxel × Genitourinary × Clear all

NCT01296243 2012-07-24

Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms

NCT01215877 2012-07-11

Tesetaxel for Previously Treated Patients With Bladder Cancer

Phase 2 Unknown

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell